ARCHIVES

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

NSAIDs Cut Oral Cancer Risk But Raise Smokers’ Heart Risk

October 28, 2005

Pepper Committee, Impressed By Progress Reports, Promises Help With NCI Funding

June 29, 1979

Two Children Achieve Remission With CD19 Immunotherapy

March 29, 2013

In Brief: Discoverer Of H. Pylori Role In Ulcers Wins Lasker Foundation Clinical Research Award

October 6, 1995

Obituaries: Keith Amos, Trudy Small, and Kie Kian Ang

June 21, 2013

ACS Challenged To Clarify Position On FDA Reform

March 1, 1996